Natural Capsules balance sheet

As of Mar 2026

Total assets: ₹424cr+1.1% on Mar 2025
Shareholders' equity: ₹235cr−8.7% on Mar 2025
Total debt: ₹114cr+10.1% on Mar 2025
Cash and investments: ₹0.2cr−68.0% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025

Non-current assets
	273	282
	3.7	0.0
	0.0	1.3
	2.7	2.7
	4.0	3.4
	6.7	6.1
	2.6	0.0
	1.0	0.0
	287	290
Current assets
	26.3	25.5
	71.4	62.2
	0.2	0.7
	4.6	4.6
	—	36.6
	76.2	104
	34.3	0.0
	137	130
	424	419
Equity
	10.4	10.3
	211	223
	222	233
	13.1	24.2
	235	257
Liabilities
	54.7	56.4
	0.7	5.3
	55.4	61.7
	1.3	0.0
	—	0.5
	56.7	62.2
	59.6	47.4
	55.3	38.5
	7.3	8.1
	122	94.0
	0.0	0.4
	1.4	0.6
	9.0	5.0
	133	100.0
	189	162
	424	419
Trade payables — MSME split
	55.3	38.5

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NATCAPSUQ₹136.44

Natural Capsules Limited

· Pharma & Health

₹ CrorePeersNECLIFE AAREYDRUGS BALPHARMA ALPA KREBSBIO MEDICAMEQ MEDICO VINEETLABMcap ₹142 Cr

View

In ₹ Crore except Per Share As of	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	282.3	273.3	273.3
+ Capital Work-in-Progress	0.0	3.7	3.7
+ Other Intangibles	1.3	0.0	0.0
+ Non-current Investments	2.7	2.7	2.7
+ Other Non-current Financial Assets	3.4	4.0	4.0
Non-current Financial Assets	6.1	6.7	6.7
+ Deferred Tax Assets	0.0	2.6	2.6
+ Other Non-current Assets	0.0	1.0	1.0
Total Non-current Assets	289.8	287.4	287.4
Current Assets
+ Inventories	25.5	26.3	26.3
+ Trade Receivables	62.2	71.4	71.4
+ Cash & Cash Equivalents	0.7	0.2	0.2
+ Other Bank Balances	4.6	4.6	4.6
+ Other Current Financial Assets	36.6	—	—
Current Financial Assets	104.1	76.2	76.2
+ Other Current Assets	0.0	34.3	34.3
Total Current Assets	129.6	136.8	136.8
Total Assets	419.4	424.2	424.2
Equity
+ Equity Share Capital	10.3	10.4	10.4
+ Other Equity / Reserves	222.6	211.2	211.2
Equity — Owners of Parent	232.9	221.6	221.6
+ Minority Interest	24.2	13.1	13.1
Total Equity	257.2	234.7	234.7
Liabilities
+ Borrowings — Non-current	56.4	54.7	54.7
+ Other Non-current Financial Liab	5.3	0.7	0.7
Non-current Financial Liabilities	61.7	55.4	55.4
+ Provisions — Non-current	0.0	1.3	1.3
+ Deferred Tax Liabilities	0.5	—	—
Non-current Liabilities	62.2	56.7	56.7
+ Borrowings — Current	47.4	59.6	59.6
+ Trade Payables	38.5	55.3	55.3
+ Other Current Financial Liab	8.1	7.3	7.3
Current Financial Liabilities	94.0	122.3	122.3
+ Provisions — Current	0.4	0.0	0.0
+ Current Tax Liabilities	0.6	1.4	1.4
+ Other Current Liabilities	5.0	9.0	9.0
Current Liabilities	100.0	132.7	132.7
Total Liabilities	162.2	189.4	189.4
Total Equity & Liabilities	419.4	424.2	424.2
Trade Payables — MSME split
+ Dues to Other Creditors — Current	38.5	55.3	55.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.